Trial Profile
A phase Ia trial of Coversin in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Apr 2016
Price :
$35
*
At a glance
- Drugs Nomacopan (Primary)
- Indications Haemolytic uraemic syndrome; Paroxysmal nocturnal haemoglobinuria
- Focus Adverse reactions
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 29 Jan 2016 Results were published in an Akari Therapeutics media release.
- 21 Jul 2015 New trial record